Factor Xa Inhibitors
Showing 1 - 25 of >10,000
Atrial Fibrillation, Anticoagulant-induced Bleeding Trial in Seoul (Factor Xa Inhibitor)
Recruiting
- Atrial Fibrillation
- Anticoagulant-induced Bleeding
- Factor Xa Inhibitor
-
Seoul, Jongno-gu, Korea, Republic ofSeoul National university Hostpital
Apr 5, 2023
Contrast Agents and Oral Factor Xa Inhibitor Trial in Bursa (computerized tomography)
Completed
- Contrast Agents and Oral Factor Xa Inhibitor
- computerized tomography
-
Bursa, TurkeyBursa Yüksek İhtisas Eğitim ve Araştırma Hastanesi
Oct 27, 2020
Health Care Interventions and Outcomes of Major Bleedings in
Not yet recruiting
- Major Bleeding
- None (Observational study)
- (no location specified)
Nov 17, 2023
Coagulation Disorder Trial (PROTHROMPLEX TOTAL, 4F-PCC)
Not yet recruiting
- Coagulation Disorder
- PROTHROMPLEX TOTAL
- 4F-PCC
- (no location specified)
Jul 14, 2022
AORTIC VALVE DISEASES, Thromboembolism Trial in Korea, Republic of (Rivaroxaban Oral Tablet, Vitamin K antagonist(warfarin))
Recruiting
- AORTIC VALVE DISEASES
- Thromboembolism
- Rivaroxaban Oral Tablet
- Vitamin K antagonist(warfarin)
-
Bucheon, Korea, Republic of
- +8 more
Oct 11, 2022
Urgent Surgery Trial (Andexanet alfa, Usual Care)
Not yet recruiting
- Urgent Surgery
- Andexanet alfa
- Usual Care
- (no location specified)
Jun 21, 2023
Outcomes in Hospitalised Patients Treated With Ondexxya
Not yet recruiting
- Hemorrhage
- Andexanet alfa
- (no location specified)
Jun 12, 2023
Dose Adjustment of Enoxaparin in ICU Patients Trial in Kfar Saba (Dose adjustment of Enoxaparin in patients with sub-therapuetic
Completed
- Dose Adjustment of Enoxaparin in ICU Patients
- Dose adjustment of Enoxaparin in patients with sub-therapuetic (prophylactic) levels of factor 10a
-
Kfar Saba, IsraelMeir Medical Center
Jan 23, 2022
Hemophilia Trial (Coagulation Factor VIIa (Recombinant))
Not yet recruiting
- Hemophilia
- Coagulation Factor VIIa (Recombinant)
- (no location specified)
Jan 12, 2023
Janus Kinase Inhibitors Vs Tumor Necrosis Factor Inhibitors in
Not yet recruiting
- Rheumatoid Arthritis
- Observation
- (no location specified)
Oct 8, 2022
Is Anti-Factor Xa Associated With Outcome in Critical COVID-19
Completed
- Covid19
- +2 more
- The effect of LMWH
- Monitoring frequency of aFXa-levels
-
Stockholm, SwedenSödersjukhuset
Feb 24, 2022
Acneiform Eruption Due to Chemical, Xerosis Cutis, Paronychia Trial (HT-001 2% Topical Gel, HT-001 1% Topical Gel, HT-001 0.5%
Not yet recruiting
- Acneiform Eruption Due to Chemical
- +2 more
- HT-001 2% Topical Gel
- +3 more
- (no location specified)
Dec 3, 2022
Hemophilia A, Hemophilia B Trial in Korea, Republic of, South Africa, Taiwan (marstacimab)
Recruiting
- Hemophilia A
- Hemophilia B
-
Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic of
- +3 more
Jan 18, 2023
Immunogenicity of TNF Inhibitors in Arthritis Poorer Treatment
Recruiting
- Arthritis, Rheumatoid
- +2 more
-
Aalborg, DenmarkDepartment of rheumatology
Sep 1, 2022
Skin Health and Quality of Life in Patients Receiving
Not yet recruiting
- Lung Cancer
- +7 more
- EQ-5D-5L questionnaire
- +2 more
-
Roma, ItalyRoberto Iacovelli
May 17, 2023
Universal Test to Quantify Apixaban, Rivaroxaban, Danaparoid and
Unknown status
- Anticoagulation
- +2 more
- Estimated anticoagulant level (conversion factor x anti-Xa activity)
- (no location specified)
Nov 30, 2020
Hemophilia A With Inhibitor, Hemophilia A With Anti Factor VIII Trial in United Kingdom, United States (Valoctocogene
Recruiting
- Hemophilia A With Inhibitor
- Hemophilia A With Anti Factor VIII
- Valoctocogene roxaparvovec
-
Los Angeles, California
- +4 more
Aug 2, 2022
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor, Factor VII Deficiency Trial in China (SS109)
Recruiting
- Hemophilia A With Inhibitor
- +2 more
- SS109
-
Hefei, Anhui, China
- +9 more
Jan 12, 2023
Anti-citrullinated Protein Antibody Status on Treatment Response
Completed
- Rheumatoid Arthritis
- Non-Interventional
-
Canberra City, Australia(unnamed)
Feb 22, 2022
Hemophilia A Trial in Metairie, New Orleans (Factor IX)
Recruiting
- Hemophilia A
- Factor IX
-
Metairie, Louisiana
- +1 more
Nov 14, 2022
Ondexxya for Intravenous Injection 200mg Drug Use Result
Recruiting
- Life Threatening Bleeding
- Factor Xa Inhibitor
-
Tokyo, JapanResearch Site
Jul 7, 2022
Hemophilia A With Inhibitors, Hemophilia B With Inhibitors Trial in Worldwide (Coagulation FVIIa (Recombinant))
Completed
- Hemophilia A With Inhibitors
- Hemophilia B With Inhibitors
- Coagulation FVIIa (Recombinant)
-
Aurora, Colorado
- +8 more
Feb 24, 2022
SGLT2 Inhibitors on Cognitive Functions and BDNF Levels in Type
Terminated
- Type2 Diabetes
- Cognitive Impairment
- MOCA cognitive evaluation test
- +3 more
-
Istanbul, TurkeyIstanbul Medeniyet University Goztepe Research and Training Hosp
Apr 16, 2022